To our knowledge, there is no report that directly shows an inhibitory effect of ginsenoside on melanin synthesis in B16 melanoma cells. Hence, we investigated whether the aglycone of Rh 4 (A-Rh4) inhibits melanin synthesis in B16 melanoma cells, and determined the mechanism of melanin inhibition. We isolated 12 ginsenoside compounds from leaves of Panax ginseng and tested them in B16 melanoma cells. It significantly reduced melanin content and tyrosinase activity under alpha-melanocyte stimulating hormone-and forskolinstimulated conditions. It significantly reduced the cyclic AMP (cAMP) level in B16 melanoma cells, and this might be responsible for the regulation down of MITF and tyrosinase. Phosphorylation of a downstream molecule, a cAMP response-element binding protein, was significantly decreased according to Western blotting and immunofluorescence assay. These data suggest that A-Rh4 has an anti-melanogenic effect via the protein kinase A pathway.
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Key words: aglycone of Rh4; melanin; tyrosinase; B16 melanoma cell; cAMP Control of melanin production is an important process in the treatment of abnormal skin pigmentation. Melanogenesis is a complex pathway involving melanin synthesis, melanin transport, and melanosome release. Melanin synthesis is stimulated by various factors including alpha-melanocyte stimulating hormone (-MSH), cyclic AMP (cAMP) elevating agents (e.g., forskolin, glycyrrhizin, and isobutylmethylxanthine), and UVB-radiation. [1] [2] [3] [4] [5] Tyrosinase, a glycosylated copper-containing oxidase with a molecular weight of 60-70 kDa, is a key enzyme in melanin biosynthesis, and its expression is closely related to melanin synthesis. 6, 7) Microphthalmia-associated transcription factor (MITF) is the most important transcription factor in the regulation of tyrosinase. 8, 9) The cAMP response element binding protein (CREB) is also one of the major transcription factors of MITF, and it plays a central role in melanogenesis. 10, 11) The CREB binding site is present in the MITF promoter region, and CREB phosphorylation is closely related to tyrosinase expression. Hence, inhibition of the cAMP pathway is a key mechanism of inhibition of melanin synthesis. 6, 12, 13) Although ginsenoside compounds are reportedly involved in the regulation of the protein kinase A (PKA) pathway, 14, 15) their modulation of melanin synthesis has not been demonstrated.
Recently, ginsenoside compounds have been developed as anticancer agents, and are commercially available as food supplements for cancer patients undergoing chemotherapy. Several reports have indicated the antiproliferative and anti-metastatic effects of ginsenosides in melanoma cells. For example, ginsenosides Rh2 and Rg3 are effective in reducing the proliferation of B16 melanoma cells. [16] [17] [18] However, the anti-melanogenic effects of ginsenoside are controversial and there is scant evidence for the anti-melanogenic effect of ginsenosides in B16 melanoma cells. Im et al. found that an extract of Radix trichosanthis reduced the melanogenesis of B16 melanoma cells, and treatment with Radix ginseng potentiated the antimelanogenic effect. 19) But, no study has directly demonstrated an inhibitory effect on melanin synthesis without reducing the proliferation of B16 melanoma cells. In the present study, we identified a novel anti-melanogenic agent by screening ginsenosides purified from Panax ginseng. Throughout our research, we tried to confirm the following (i) inhibitory effect of aglycone of Rh4 (ARh4) on melanin synthesis in B16 melanoma cells and (ii) mechanism for action of melanin inhibition.
Materials and Methods
Materials. Forskolin, -MSH, 4 0 ,6-diamidino-2-phenylindole (DAPI) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO). Antibodies that recognize CREB and phospho-specific CREB (Ser133) were from Cell Signaling (Danvers, MA). Antibodies that recognize MITF, tyrosinase and actin were from Santa Cruz (Santa Cruz, CA). Cell culture. B16 murine melanoma cells were purchased from the Korean Cell Line Bank (Seoul, Korea). The cells were maintained in Dulbecco's Modified Eagles Medium (DMEM), and supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT) and 1% penicillin-streptomycin in 5% CO 2 at 37 C.
Cytotoxicity assay. Cell viabilities were determined for 12 ginsenosides ( Fig. 1 ) by crystal violet assay. After incubation of cells with test substances for 24 h, the media were removed, and the cells were stained with 0.1% crystal violet in 10% ethanol for 10 min at room temperature. They were then rinsed 4 times with distilled water, and the crystal violet retained by adhering cells was extracted using 95% ethanol. Absorbance was determined at 590 nm using an ELISA reader (Tecan, Grodig, Austria).
Measurement of melanin contents. Extracellular melanin release was measured as described previously, with slight modifications. 20, 21) B16 cells were incubated at a density of 1 Â 10 5 cells in six-well plates overnight. -MSH (1 mm) or forskolin (20 mm) was then added, and the cells were treated with increasing concentrations of test substances in phenol red free DMEM for 5 d. Two hundred-mL aliquots of media were then transferred to 96-well plates and optical densities (OD) were measured at 400 nm using an ELISA reader. A standard curve for synthetic melanin (<300 mg/mL) was prepared for each experiment. Melanin production were expressed as percentage of untreated controls.
Tyrosinase activity. Tyrosinase activities were determined as previously described. 20, 21) Cells were cultured in six-well plates, incubated with A-Rh4 in phenol red free DMEM for 5 d, washed with ice-cold PBS, and lysed with phosphate buffer (pH 6.8) containing 1% Triton X-100. The cells were then disrupted by freeze-thawing, and lysate was clarified by centrifugation at 10;000 g for 5 min. After quantification of protein levels by Bradford assay and adjusting concentrations with lysis buffer, 90 mL of each lysate was placed in the wells of a 96-well plate, and 10 mL of L-DOPA (10 mM) was added. Control wells contained 90 mL of lysis buffer and 10 mL of L-DOPA. The absorbance was measured every 10 min for at least 1 h at 475 nm with an ELISA reader. A cell-free assay system was used to investigate the direct effects of the test substances on tyrosinase activity. Seventy mL of phosphate buffer containing test substances was mixed with 20 mL of 10 mg/mL mushroom tyrosinase, and 10 mL of 10 mM L-DOPA was then added. Following incubation at 37 C, the absorbance was measured at 475 nm.
Western blotting. Protein samples were prepared in RIPA buffer 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 1% SDS, 50 mM NaF, 1 mM Na 3 VO 4 , 5 mM dithiothreitol, 1 mg/ mL leupeptin, and 1 mM PMSF. Samples were separated on 12% SDSpolyacrylamide gels and transferred to polyvinylidene fluoride (PVDF) membranes, which were blocked with 5% dried milk in PBS containing 0.4% Tween-20. The blots were incubated with the appropriate primary antibodies at a dilution of 1:1,000. Membranebound primary antibodies were detected using secondary antibodies conjugated with horseradish peroxidase and ImmunobilonÔ Western Chemiluminescent HRP Reagent (Millipore, Bedford, MA), and exposed to Agfa X-ray film. Reverse transcription-polymerase chain reaction (RT-PCR). Total cellular RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA), followed by reverse transcription using a cDNA synthesis kit (Promega, Madison, WI). cDNA was synthesized from 1 mg total RNA using 200 U of reverse transcriptase (M-MLV RT) and 50 ng/L oligo(dT). The cDNA obtained was amplified with the following primers: MITF forward 5CCCGTCTCTGGAAACTTGATCG-3 d, the reverse 5CTGTACTCTGAGCAGGTG-3, tyrosinase forward 5GGCC-AGCTTTCAGGCAGAGGT-3, and reverse 5TGGTGCTTCATGGG-CAAAATC-3. PCR was performed in a final volume of 25 mL of reaction mixture that contained 2 mL of the RT reaction mixture, 15 
cAMP immunoassay. cAMP levels were analyzed using a cAMP kit from R&D systems (Minneapolis). A-Rh4-treated B16 cells were lysed in 0.1 M of HCl to inhibit phosphodiesterase activity. Supernatants were collected, neutralized, and diluted. Following neutralization and dilution, a fixed amount of cAMP conjugate (alkaline phosphatelabeled cAMP) was added to compete with cAMP in the cell lysates. After a washing to remove excess conjugated and unbound cAMP, a substrate solution was added to the wells to determine the bound enzyme activity. Color development was stopped and the absorbance was measured at 405 and 420 nm.
Immunofluorescence microcopy. B16 cells were cultured directly on glass cover-slips. They were fixed with 3.5% paraformaldehyde in PBS for 10 min at room temperature, and then were permeabilized with 100% methanol for 10 min. To evaluate the phosphorylation of CREB, the cells were treated with antibody against phospho-CREB overnight (1:1,000 dilution in PBS). Then They were washed with PBS and incubated with a secondary fluorescein isothiocyanate (FITC)-conjugated donkey anti-rabbit IgG antibody (1:500 dilution) for 1 h at room temperature. Finally, the nuclei were stained with 1 mg/mL of 4,6-diamidino-2-phenylindole (DAPI), and then analyzed by fluorescence microcopy (ECLIPSE E600, Nikon, Japan).
Statistics. All data are presented as mean AE STD. Differences among treatments were assessed by analysis of variance (ANOVA), followed by Dunnett's test. p values < 0:05 were considered to be significant.
Results

Effect of ginsenosides on the melanin production of B16 melanoma cells
We screened the anti-melanogenic compound, in B16 melanoma cells, but only A-Rh4 significantly reduced the melanin content ( Fig. 2A) .
Characterization of A-Rh4
A-Rh4 was isolated from a sub-fraction of F1.4.6 by chromatography. The UV, FAB-MS, and NMR data for aglycone of Rh4 were in good agreement with previously reported results. 22 
Inhibitory effect of A-Rh4 in -MSH-induced melanogenesis
To determine whether A-Rh4 has a cytotoxic effect on B16 cells, we applied a 1-50 mM concentration of A-Rh4 and measured cell viability by crystal violet staining assay. As shown in Fig. 2B , A-Rh4 was found to have no cytotoxic effect on B16 cells at these concentrations.
After -MSH stimulation, the melanin content of the B16 melanoma cells was measured. -MSH-induced melanin levels were significantly inhibited by A-Rh4 treatment in a dose-dependent manner (concentration 1-50 mM) and 50 mM A-Rh4 showed a comparable effect for 100 mM arbutin (Fig. 3A) . We also examined -MSH-induced tyrosinase activity. A-Rh4 decreased -MSH-induced tyrosinase activity in the B16 cells (Fig. 3B) . These results indicate that A-Rh4 is negatively involved in tyrosinase activity and subsequently suppresses -MSH-mediated melanin synthesis in B16 cells.
We hypothesize that A-Rh4 affects, MITF and tyrosinase expression. These play important roles in melanogenesis. To test this hypothesis the protein expression of MITF and tyrosinase were measured after 72 h of A-Rh4 treatment. A-Rh4 clearly decreased -MSH-induced MITF and tyrosinase protein expression (Fig. 3C) . Since decreased MITF and tyrosinase mRNA expression may be responsible for the decreased levels of protein, mRNA expression of MITF and tyrosinase was measured by RT-PCR. As expected, A-Rh4 significantly decreased -MSH-mediated MITF and tyrosinase mRNA expression (Fig. 3D) .
PKA pathway involvement -MSH binds to the melanocortin 1 receptor, and this leads to activation of the PKA pathway, which might trigger MITF and tyrosinase transcription regulation. Hence, A-Rh4 was investigated for its influence on melanin synthesis via this pathway. Forskolin, a direct activator of adenylate cyclase, increased melanin production, but was reduced by A-Rh4 treatment (Fig. 4A) . In addition, A-Rh4 reduced forskolin-induced tyrosinase activity in the B16 cells (Fig. 4B) . Western blot experiments revealed significant regulation down of MITF and tyrosinase expression after A-Rh4 treatment in forskolin-treated cells (Fig. 4C) . RT-PCR experiments also indicated that the mRNA expression of these enzymes was significantly regulated down by A-Rh4 treatment (Fig. 4D) .
cAMP-mediated CREB phosphorylation
Because inhibition studies suggest that the PKA pathway is activated by A-Rh4 treatment, the intracellular cAMP levels of B16 melanoma cells were measured after A-Rh4 treatment. As shown in Fig. 5A , A-Rh4 significantly inhibited -MSH-induced intracellular cAMP levels, indicating that A-Rh4 mediates the inhibition of melanogenesis by cAMP regulated down. To elucidate the downstream mechanism, we examined to determine whether A-Rh4 affects, CREB phosphorylation, which might mediate cAMP-induced MITF expression. Although -MSH induced CREB phosphorylation, this effect was attenuated by A-Rh4 treatment (Fig. 5B) . Immunofluorescence experiments with the monoclonal anti-phospho-CREB antibody also indicated that -MSH increased the phosphorylation of CREB, but A-Rh4 treatment significantly decreased it (Fig. 5C ). Collectively, these results indicate the pivotal involvement of the PKA pathway in A-Rh4 mediated antimelanogenesis in B16 melanoma cells.
Discussion
In this study, we identified a novel anti-melanogenic agent among ginsenoside compounds. We isolated and tested 12 ginsenoside compounds that had no effect on the viability of B16 melanoma cells. The anti-melanogenic effect was tested, and only A-Rh4 showed an antimelanogenic effect on B16 melanin cells. It significantly reduced the melanin content and tyrosinase activity of -MSH-stimulated cells. This was due to regulated down of MITF and tyrosinase expression. A-Rh4 also reduced the melanin content and tyrosinase activity of forskolinstimulated cells. In a mechanism study, A-Rh4 reduced cAMP levels in B16 melanoma cells. Phosphorylation of a downstream molecule, CREB, was significantly decreased according to Western blotting and immunofluorescence assay. Collectively, these data suggest that A-Rh4 has an anti-melanogenic effect via regulation of the PKA pathway.
In a preliminary study, we investigated to determine whether A-Rh4 can modulate other melanogenic proteins such as tyrosinase-related proteins (TRPs), but the results showed that their mRNA and protein expression were not affected by A-Rh4 treatment (data not shown). In addition, A-Rh4 did not directly inhibit mushroom tyrosinase activity, but A-Rh4 treatment reduced the mRNA and protein expression of MITF and tyrosinase in -MSH-and forskolin-induced systems. It is plausible that the A-Rh4-induced decrease in cellular cAMP levels is primarily involved in the down-regulation of MITF and tyrosinase. noma cells, and treatment with Radix ginseng potentiated the antimelanogenic effect of this plant. 19) However, no absurd has directly demonstrated the inhibitory effect of ginsenoside compounds on melanin synthesis without reduction of the proliferation of B16 melanoma cells. This present study is the first indication that A-Rh4 can be used for inhibition of melanin synthesis without reducing cell viability.
A-Rh4 is not a major compound that can be obtained by a separation of the Panax ginseng leaf. Under the conditions of our separation, ginsenoside Rd and 20(S)-ginsenoside Rg 1 were isolated from the ginseng leaf. In this study, certain ginsenosides slightly decreased mushroom tyrosinase activity, but they did not reduce melanin production in a cell-based system. Although we did not measure human tyrosinase activity, a reduction in the melanin contents of B16 melanin cells implies anti-melanogenic effects. However, since the extraction yield for A-Rh4 was very low (only 68 mg from 5 kg of dried leaves) and thus cannot produce ARh4 on a large scale, it is necessary to find a better method of obtaining A-Rh4 by chemical synthesis or fermentation of other ginsenosides.
We identified a novel anti-melanogenic ginsenoside that decreases melanin production without reducing the viability of B16 melanin cells. This is the first indication that A-Rh4 has an anti-melanogenic effect through regulation down of MITF and tyrosinase expression. Regulation down of melanogenic enzymes was mediated by the PKA pathway. Because the production yield of A-Rh4 was very low, either derivatives of Rh4 or products of the chemical synthesis of these compounds should be developed for large scale production in order to apply Rh4 product to the skin. Note that A-Rh4 attenuated the -MSH-induced CREB phosphorylation. B16 melanoma cells were stimulated with -MSH (1 mM), and treated with or without A-Rh4 (20 mM) for 1 h. Measurement of cAMP levels (A) Western blot analysis of phosphorylated CREB (B). Fluorescence microscope image for phosphorylated CREB (C).
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